Topics

Companies Related to "Ovarian Cancer Risk Estimation in Patients With Pelvic Mass" [Most Relevant Company Matches] RSS

01:25 EDT 21st September 2019 | BioPortfolio

Here are the most relevant search results for "Ovarian Cancer Risk Estimation in Patients With Pelvic Mass" found in our extensive corporate database of over 50,000 company records.

Showing "Ovarian Cancer Risk Estimation Patients With Pelvic Mass" Companies 1–25 of 6,900+

Extremely Relevant

National Ovarian Cancer Coalition

For more than 25 years, the National Ovarian Cancer Coalition has been committed to raising awareness, promoting education, and funding research in support of women, families and communities touched by ovarian cancer. The NOCC is an important national advocate for patients and families struggling with ovarian cancer, and remains steadfast in its mission “to save lives by fighting tirelessly ...


Ovarian Cancer Institute

The Ovarian Cancer Institute is a 501(c)(3) organization dedicated to ovarian cancer research. The work focuses on accurate diagnostics and improved therapeutics. Creators of a first-of-its-kind, early-stage ovarian cancer detection test, the Ovarian Cancer Institute aims to change the future of women suffering from this disease.

The Pelican Cancer Foundation

The Pelican Cancer Foundation is a unique charity, dedicated exclusively to curing cancer patients by advancing the latest techniques of precision surgery.The Charity derives its name from the words Pelvic and Liver Cancer.Formed in 2000, it was based around the pioneering work ofProfessor ‘Bill’ Heald OBE, Mr Brendan Moran and colleagues at the North Hampshire Hospital in bowel cancer surgery...


Sandy Rollman Ovarian Cancer Foundation

The Sandy Rollman Ovarian Cancer Foundation, a 501 (c) (3) non-profit, now celebrating its 17th year, was created as a tribute to the life, character, and immense strength of Sandy Rollman. Sandy passed away from advanced ovarian cancer in May 2000. Prior to diagnosis, Sandy experienced many textbook symptoms. Her symptoms were whispering only no on...

Relevant

Avant Diagnostics, Inc.

Avant Diagnostics, Inc. is a medical diagnostic technology company that specializes in large panel biomarker screening. Our first test, OvaDx®, developed in conjunction with Arrayit Corporation (OTCQB: ARYC), detects for pre-symptomatic ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system i...

Color Genomics

Color Genomics provides a high-quality, physician-ordered, genetic test for 19 genes related to breast and ovarian cancer risk, including BRCA1 and BRCA2. The Color Test includes support for physicians, as well as genetic counseling as part of every order. Color’s goal is to expand physician-supported access to genetic information for breast and ovarian ...

Propanc Biopharma, Inc.

Propanc Biopharma, Inc. (the "Company") is a biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a formulation of anti-cancer compounds, which exert a number of effects designed to control or prevent tumors from recurring and spreading through...

Indiana Women's Oncology

We actively enroll patients in Indiana Women's Oncology (IWO) protocols. The IWO is a multicenter group which runs multiple therapeutic and diagnostic trials sponsored by the National Cancer Institute. These trials touch all aspects of care of the women with cancers of the reproductive tract. Current trials include developing new agents for ovarian cancer, utilizing antibodies to treat some ovaria...

US Bioscience Incorporated

US Bioscience, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for patients with cancer and allied diseases such as AIDS. Currently, three of the Company's products are marketed by US Bioscience and its commercial partners: Ethyol® (amifostine) A selective cytoprotective agent for reduction of toxicities associated with cancer chemotherapy. Hexalen...

Renovia Inc.

Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Renovia's technology enables treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, while monitoring usa...

The Institute for Female Pelvic Medicine & Reconstructive Surgery

The Institute for Female Pelvic Medicine & Reconstructive Surgery is a center for excellence for the comprehensive evaluation and management of female pelvic health, integrating effective medical training, innovative clinical research and service-oriented patient care.

Signet Laboratories Incorporated

Signet Laboratories, Inc is a medical biotechnology company focused in fields of cancer and infectious disease(Sepsis). Signet has developed proprietary antibody systems for the detection and management of breast and prostate cancer and Sepsis. Signet's patented technology will provide for determining risk in "normal patients who may be at increased risk for developing cancer at a time when proac...

Oncimmune (USA) LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of six immuno-biomarkers (autoantibodies) above a predetermined cutoff value suggests that a tumor might be present. This simple blood test aids in risk assessment and the early detection of lung cancer...

Oncimmune LLC

Oncimmune's EarlyCDT-Lung test uses a panel of tumor antigens to detect the presence of immuno-biomarkers produced in the form of autoantibodies by the patient's immune system. Elevation of any one of six immuno-biomarkers (autoantibodies) above a predetermined cutoff value suggests that a tumor might be present. This simple blood test aids in risk assessment and the early detection of lung cancer...

OvaGene Oncology Inc.

OvaGene Oncology is a molecular diagnostics company, located in Orange County, California, dedicated to improving cancer care and outcomes for gynecologic cancer patients through the development of novel gene-based assays. The company plans to offer proprietary and non-proprietary molecular diagnostic assays to assist physicians in the prognosis of gynecologic cancers as well as therapy selection...

The Ovarian Cancer Research Fund

The Colorado Ovarian Cancer Alliance

Ovarian Cancer Coalition of Greater California

Access Pharmaceuticals, Inc.

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase II clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug del...

Ortho Biotech, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients'...

Ortho Biotech Products, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients'...

IncellDx, Inc.

IncellDx, Inc. is a molecular diagnostics company dedicated to revolutionizing healthcare one cell at a time. By combining molecular diagnostics with high throughput cellular analysis, we focus on critical life threatening diseases such as HIV/AIDS, HPV/Cervical Cancer, Hepatitis, organ transplant infections, breast cancer and ovarian cancer.

Verastem Oncology

Verastem, Inc. (Nasdaq:VSTM), operating as Verastem Oncology, is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients. Verastem Oncology is currently developing duvelisib, a dual inhibitor of PI3K-delta and PI3K-gamma, which has successfully met its primary endpoint i...

Blue Ridge Cancer Care

Blue Ridge Cancer Care (BRCC) is an independent private practice of 19 physicians specializing in the diagnosis and treatment of cancer and blood disorders. BRCC’s ten convenient locations throughout the southwest region of Virginia provide comprehensive and cutting-edge cancer care closer to where patients live. BRCC provides a number of services and...

ViRexx Medical

ViRexx Medical Corp. is an Edmonton, Alberta based biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and chronic viral infections. ViRexx's most advanced programs include drug candidates for the treatment of ovarian cancer, chronic Hepatitis B & C and solid tumors. The lead product from the AIT™ platform is OvaRex® MAb, a therapy for lat...


More From BioPortfolio on "Ovarian Cancer Risk Estimation in Patients With Pelvic Mass"

Quick Search

Corporate Database Quicklinks